Colinz Labs shareholders approve all resolutions at 40th AGM
- All four resolutions at the 40th AGM passed with requisite majority
- Promoters voted in favour of all leadership reappointments
- Only 6 votes against recorded across all resolutions
- No physical attendance; all participation via VC/OAVM

*this image is generated using AI for illustrative purposes only.
Colinz Laboratories Limited shareholders have approved all resolutions proposed at the company's 40th Annual General Meeting, held on September 22, 2026. The voting results, disclosed on September 23, 2026, confirm the adoption of FY26 financial statements and key governance changes.
The meeting was conducted via Video Conferencing or Other Audio Video Means (OAVM). Mrs. Vijaya Mani served as Chairperson. She confirmed the presence of a quorum and acknowledged the sad demise of Late Dr. Mani L.S., the Founder Director and Promoter, during the financial year.
Key resolutions approved
The Board commended several items of business for member approval, covering both ordinary and special business. The audited financial statements for the year ended March 31, 2026, along with the reports of the Board of Directors and Auditors, were adopted.
| Resolution | Type | Details |
|---|---|---|
| Adoption of Financial Statements | Ordinary | For the year ended March 31, 2026 |
| Reappointment of Director | Ordinary | Mr. N. K. Menon (DIN-01111297) retiring by rotation |
| Appointment of Director | Ordinary | Mrs. Vijaya Mani (DIN: 11363910) as Non-Executive Non-Independent Director |
| Reappointment of CEO | Special | Mr. N. K. Menon as Whole Time Director & Chief Executive Officer |
Governance updates
Mr. N. K. Menon, who serves as the Whole Time Director and Chief Executive Officer, was reappointed following his retirement by rotation. Additionally, members approved his continued remuneration package through a special resolution. Mrs. Vijaya Mani was formally appointed as a Director in her capacity as a Non-Executive Non-Independent Director.
Voting results and attendance
The scrutinizer's report dated September 23, 2026, detailed the voting outcomes. A total of 32 shareholders participated in the voting process, combining remote e-voting and electronic voting during the meeting. Notably, no shareholders attended the meeting in person or through proxy.
Attendance via Video Conferencing included 14 promoters/promoter group members and 18 public shareholders. The total number of shareholders on record was 3,195.
Resolution-wise voting summary
| Resolution | Votes in Favour | Votes Against | Result |
|---|---|---|---|
| Adoption of Financial Statements | 12,61,269 | 6 | Passed |
| Reappointment of Director (N.K. Menon) | 12,61,169 | 6 | Passed |
| Appointment of Director (Vijaya Mani) | 3,90,769 | 6 | Passed |
| Reappointment of CEO (N.K. Menon) | 12,61,169 | 6 | Passed |
The promoters and promoter group held 12,74,659 shares and cast votes on 8,70,500 shares for most resolutions, voting entirely in favour. Public non-institutional shareholders voted on approximately 3,90,675 shares, with only 6 votes cast against across all resolutions.
The meeting concluded at 3:03 pm after the Chairperson informed members that the results of the e-voting would be reconciled by the Scrutinizer, M/s. Ashwini Vaze & Associates. The final report is now available on the company website and relevant stock exchange platforms.
Historical Stock Returns for Colinz Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | -4.15% | 0.0% | 0.0% | 0.0% | 0.0% |
How will the formal appointment of Mrs. Vijaya Mani as a Non-Executive Non-Independent Director influence Colinz Laboratories' strategic direction following the passing of founder Dr. Mani L.S.?
What are the implications of the extremely low shareholder participation (less than 1% of registered holders) for the company's future corporate governance credibility and market perception?
Will the reappointment of CEO N.K. Menon with an approved remuneration package signal a continuation of existing operational strategies or indicate a shift in management priorities for FY27?

































